SCHEMBL4599391

SCHEMBL4599391

CS(=O)(=O)Oc1cc[c]c(NCc2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.40
FAAH O00519 1/20 0.40
CA2 P00918 5/20 0.39
CA12 O43570 3/20 0.39
CA7 P43166 2/20 0.39
CA14 Q9ULX7 2/20 0.39
ALDH1A1 P00352 3/20 0.38
ALDH1A2 O94788 1/20 0.38
ALDH1B1 P30837 1/20 0.38
ALDH1A3 P47895 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CA1 P00915 4/20 0.36
CA9 Q16790 1/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4598731 0.85 ALDH1A1 (0.41) HTTFAAHCA2CA12CA7
SCHEMBL4599999 0.83 L3MBTL1 (0.45) HTTCA12ALDH1A1LMNAMAPT
SCHEMBL4599588 0.81 KDM4E (0.37) HTTFAAHCA2CA12ALDH1A1
SCHEMBL4599161 0.79 HTT (0.49) HTTCA2CA12ALDH1A1LMNA
SCHEMBL3456084 0.77 BCHE (0.53) ALDH1A1MAPTSMN1; SMN2
SCHEMBL4598887 0.77 CA12 (0.35) FAAHCA2CA12CA14ALDH1A1
SCHEMBL4599912 0.76 ALDH1A1 (0.38) CA2CA12ALDH1A1ALDH1A2ALDH1B1
SCHEMBL4600346 0.75 APLNR (0.48) ALDH1A1LMNA
SCHEMBL4598688 0.73 TDP1 (0.43) HTTFAAHALDH1A1LMNAMAPT
SCHEMBL4611281 0.73 FAAH (0.40) FAAHCA2CA12ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed